Doctor taking notes

Resources

Publications

Apr 2023
Safety, Pharmacokinetics, & Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-associated Hepatitis
Tarek Hassanein, Craig J. McClain, Vatsalya Vatsalya, Lance L. Stein, Steven L. Flamm, Paul Martin, Matthew C. Cave, Mack Mitchell Jr, Bruce Barton, Laura Nagy, Gyongyi Szabo, Arthur McCullough, Srinivasin Dasarathy, Jaymin Shah, Christina Blevins, Deborah Scott, William Krebs, James E. Brown, WeiQi Lin  | The American Journal of Gastroenterology
Mar 2023
Alcohol-associated Hepatitis as a Secondary Diagnosis: Comparisons of Medicare Patient Outcomes and Hospital Financial Performance, 2017-2019
Natalie Marlowe, Robert C. Saunders, Clarisa Peer, Keith Lui, Julia Sheriff, Lane Koenig, Norman Sussman | AMCP
Dec 2022
A Phase 2b Trial in Alcohol-associated Hepatitis to Evaluate the Safety and Efficacy of Larsucosterol Treatment (AHFIRM)
Christina Blevins, Deborah Scott, Gwenaelle Mille, Jina Lee, Gail Friedt, Norman Sussman | SCSG GI Symposium
Nov 2022
The Inpatient Cost and Utilization Impact of Alcohol-associated Hepatitis (AH) Among Traditional Medicare Beneficiaries, 2017-2019
Natalie Marlowe, Robert C. Saunders , Clarisa Peer, Keith Lui, Brendan Gage, Lane Koenig , Norman Sussman | AASLD The Liver Meeting
Jul 2022
Prevalence, Co-Morbidities, And In-Hospital Mortality of Patients Hospitalized with Alcohol-Associated Hepatitis in the United States from 2015 to 2019
Natalie Marlowe, David Lam, William Krebs, WeiQi Lin, Suthat Liangpunsakul | Alcoholism: Clinical and Experimental Research

Factsheets

See the resources included here for more information and resources from DURECT.

In the News

Scroll to Top